Epic journey yields unique offering - Insights
The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.
Cross-laboratory collaboration accelerates gold-standard SRA testing - Insights
Utilizing testing capabilities of two separate laboratory facilities, Mayo Clinic Laboratories’ new serotonin release assay (SRA) is a gold-standard test supported by decades of clinical hematopathologic experience and advanced mass...
Gastroenterology Testing - Mayo Clinic Laboratories
All in One Place. From screening to therapeutic management, we offer a comprehensive,one-stop solution for gastroenterlogy test ordering.
Epansive clinical test menu, including more than 3,500 CAP- and CLIA-accredited tests. In addition to offering the world’s most sophisticated specialty test menu, we provide access to research-grade tests, pathology services, and sponsored...
Autoimmune Neurology Testing - Mayo Clinic Laboratories
Recognized as a world leader in the diagnosis and treatment of autoimmune neurologic disorders, Mayo Clinic mounts unmatched resources for developing new diagnostic biomarkers and unique laboratory tests.
Mayo Clinic Laboratories isn’t just a reference lab. We’re also the diagnostic lab for a hospital, just like your lab. So we know the many benefits of keeping tests as close to patients as possible.
A collaboration with Mayo Clinic BioPharma Diagnostics includes access to the neurologic disease testing capabilities of Mayo Clinic Laboratories. Our highly specialized neurology testing menu features more than 400 neurologist-backed...
A novel testing approach for newly identified VEXAS syndrome - Insights
VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...
Enhanced technology safeguards patient specimens - Insights
Mayo Clinic's use of enhanced radio-frequency identification technology to track specimens from the clinical setting to the lab reduces the risk of errors and protects valuable — sometime irreplaceable — patient samples.
New tests launched in December - Insights
December 2021, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.